Every open market buy and sale of Denali Therapeutics Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $1.3M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when DNLI insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an DNLI officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every DNLI insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Peter Scott ChinChief Medical Officer | Sale | 1,654 | $22.29 | $37K | 204,538 | Sep 9Form 4 |
| Sep 2, 2026 | Nancy ThornberryDirector | Sale plan | 11,439 | $22.90 | $262K | 19,686 | Sep 4Form 4 |
| Sep 1, 2026 | Alexander O. SchuthCOFO and Secretary | Sale plan | 2,768 | $23.44 | $65K | 278,995 | Sep 3Form 4 |
| Aug 11, 2026 | Alexander O. SchuthCOFO and Secretary | Sale | 2,857 | $25.07 | $72K | 281,763 | Aug 13Form 4 |
| Jan 6, 2026 | Ryan J. WattsPresident and CEO | Sale | 35,198 | $16.50 | $581K | 296,833 | Jan 8Form 4 |
| Jan 6, 2026 | Alexander O. SchuthCOFO and Secretary | Sale | 17,218 | $16.50 | $284K | 282,828 | Jan 8Form 4 |
| Aug 13, 2025 | Carole HoChief Medical Officer | Sale plan | 3,743 | $13.81 | $52K | 216,585 | Aug 14Form 4 |
| Aug 12, 2025 | Alexander O. SchuthCOFO and Secretary | Sale | 2,937 | $13.58 | $40K | 242,346 | Aug 14Form 4 |
| Jul 9, 2025 | Ryan J. WattsPresident and CEO | Sale plan | 495,282 | $15.00 | $7.4M | 253,071 | Jul 11Form 4 |
| Jan 7, 2025 | Steve E. KrognesDirector | Sale | 3,339 | $20.81 | $69K | 25,757 | Jan 8Form 4 |
| Jan 7, 2025 | Ryan J. WattsPresident and CEO | Sale | 36,916 | $20.34 | $751K | 253,071 | Jan 8Form 4 |
| Jan 7, 2025 | Alexander O. SchuthCOFO and Secretary | Sale | 15,162 | $20.33 | $308K | 244,308 | Jan 8Form 4 |
| Jan 7, 2025 | Carole HoChief Medical Officer | Sale | 15,162 | $20.33 | $308K | 175,673 | Jan 8Form 4 |
| Jan 2, 2025 | Vicki L SatoDirector | Sale plan | 3,080 | $20.91 | $64K | 107,976 | Jan 3Form 4 |
| Dec 31, 2024 | Steve E. KrognesDirector | Sale plan | 30,000 | $20.25 | $608K | 29,096 | Jan 3Form 4 |
DNLI insider trading FAQ
Are DNLI insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of DNLI on the open market in 0 trades, and 4 sold $1.3M in 6 trades, 25% of that under pre-arranged trading plans.
When did an DNLI insider last buy shares?
There has been no open market insider purchase of DNLI in the last two years.
When did an DNLI insider last sell shares?
Peter Scott Chin (Chief Medical Officer) sold 1,654 shares for $37K on Sep 4, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
